Publikationen
Journalbeiträge 2008
Originalarbeiten
- Linnemann B, Meister F, Schwonberg J, Schindewolf M, Zgouras D, Lindhoff-Last E; MAISTHRO registry. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry. Thromb Haemost. 2008 Sep; 100(3): 440-446.
- Gerdsen F, Luxembourg B, Langer F, Bauersachs R, Lindhoff-Last E. A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparin. Blood Coagul Fibrinolysis. 2008 Sep; 19(6): 477-481.
- Berger M, Moscatelli H, Kulle B, Luxembourg B, Blouin K, Spannagl M, Lindhoff-Last E, Schambeck CM. Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism. Thromb Haemost. 2008 May; 99(5):905-908.
- Linnemann B, Schmidt H, Schindewolf M, Erbe M, Zgouras D, Grossmann R, Schambeck C, Lindhoff-Last E. Etiology and VTE risk factor distribution in patients with inferior vena cava thrombosis. Thromb Res. 2008;123(1):72-78.
Epub 2008 Mar 4. - Linnemann B, Zgouras D, Schindewolf M, Schwonberg J, Jarosch-Preusche M, Lindhoff-Last E. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry. Blood Coagul Fibrinolysis. 2008 Mar; 19(2): 159-165.
- Mani H, Toennes SW, Linnemann B, Urbanek DA, Schwonberg J, Kauert GF, Lindhoff-Last E. Determination of clopidogrel main metabolite in plasma: a useful tool for monitoring therapy? Ther Drug Monit. 2008 Feb; 30(1): 84-89.
- Linnemann B, Schwonberg J, Mani H, Prochnow S, Lindhoff-Last E. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost. 2008 Apr; 6(4): 677-683. Epub 2008 Jan 8.
- Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? Thromb Res. 2008; 121(6): 743-750. Epub 2007 Sep 4.
Case Reports
- Schindewolf M, Lindhoff-Last E. Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses. Thromb Haemost. 2008 Apr; 99(4): 776-778.
- Schindewolf M, Ludwig RJ, Wolter M, Himsel A, Zgouras D, Kaufmann R, Boehncke WH, Lindhoff-Last E. Tolerance of fondaparinux in patients with generalized contact dermatitis to heparin. J Eur Acad Dermatol Venereol. 2008 Mar; 22(3): 378-380.
Reviews
- Lindhoff-Last E. How safe is our treatment with heparins? MMW Fortschr Med. 2008 May 29; 150 (22): 7.
- Lindhoff-Last E, Luxembourg B. Evidence-based indications for thrombophilia screening. Vasa. 2008 Feb; 37(1): 19-30.
- Lindhoff-Last. Globaltest versus Profil: Wird das endogene Thrombinpotential das etablierte Thrombophiliescreening ablösen? Contra / Global coagulation assays versus differentiated testing: will endogenous thrombin potential replace established thrombophilia screening? Contra. Laboratoriums-Medizin. 2008; 32 (4): 197-199
Letter
- Schindewolf M, Lindhoff-Last E. Fondaparinux-related thrombocytopenia in a patient with former HIT. (Response to Rota et al. Thromb Haemost 2008; 99: 779-781.) Thromb Haemost. 2008 Jul; 100 (1): 168-169; author reply 169-170.